184
Participants
Start Date
June 10, 2021
Primary Completion Date
August 1, 2024
Study Completion Date
October 24, 2024
Financial incentives
Escalating financial rewards for saliva cotinine levels \<30 ng/mL, assessed 10 times over 12 weeks
Varenicline
"* Day 1 - 3: 0.5 mg daily~* Day 4 - 7: 0.5 mg twice daily~* Day 8 - Week 12: 1 mg twice daily~* Dose/schedule may be adjusted based on medical history and clinician judgement"
Tobacco coaching
5 one-on-one tobacco cessation coaching sessions over 12 weeks
Boston Health Care for the Homeless Program, Boston
National Cancer Institute (NCI)
NIH
National Institutes of Health (NIH)
NIH
Massachusetts General Hospital
OTHER